GERN Competitors & Alternatives
Compare Geron Corporation with similar stocks in the same industry
Biotechnology
GERN
Main Stock$1.52
Tradestie Score
42
Market Cap
$899.60M
Revenue Growth
0.2%
Analyst Upside
+179.6%
Top Competitors
239 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$11.85
|
$1.05B | 84.6 | 36 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.33
|
$1.01B | 107.5 | 51 | Compare |
|
SPRY
ARS Pharmaceuticals, Inc. Common Stock
|
$5.51
|
$997.16M | - | 46 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$3.39
|
$996.55M | - | 41 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$106.49
|
$994.20M | - | 41 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$6.96
|
$993.46M | - | 33 | Compare |
|
IMNM
Immunome, Inc.
|
$28.52
|
$987.09M | - | 31 | Compare |
|
BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
|
$9.08
|
$952.74M | - | 50 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$3.91
|
$951.83M | - | 33 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
More GERN Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
239 stocks in this industry